NAPROXEN
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
51655-621 -
Package NDC
51655-621-20 -
Package NDC
51655-621-25 -
Package NDC
51655-621-83 -
Application number
ANDA091416 -
SPL ID
494f2182-140c-e7cc-e063-6394a90a093a -
SPL set ID
f32d755e-4984-ee40-e053-2995a90a4ebe -
UNII
57Y76R9ATQ -
RxCUI
198014
What the source publishes
- Labeler
- Northwind Health Company, LLC
- Active ingredients
- NAPROXEN
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "NAPROXEN",
"splId": "494f2182-140c-e7cc-e063-6394a90a093a",
"labels": [
{
"setId": "f32d755e-4984-ee40-e053-2995a90a4ebe",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f32d755e-4984-ee40-e053-2995a90a4ebe",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f32d755e-4984-ee40-e053-2995a90a4ebe"
}
],
"routes": [
"ORAL"
],
"labeler": "Northwind Health Company, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "20 TABLET in 1 BOTTLE, PLASTIC (51655-621-20)",
"package_ndc": "51655-621-20",
"identifierStatus": "well-formed",
"marketing_start_date": "20200706"
},
{
"sample": false,
"description": "60 TABLET in 1 BOTTLE, PLASTIC (51655-621-25)",
"package_ndc": "51655-621-25",
"identifierStatus": "well-formed",
"marketing_start_date": "20200706"
},
{
"sample": false,
"description": "180 TABLET in 1 BOTTLE, PLASTIC (51655-621-83)",
"package_ndc": "51655-621-83",
"identifierStatus": "well-formed",
"marketing_start_date": "20200706"
}
],
"productId": "51655-621_494f2182-140c-e7cc-e063-6394a90a093a",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "51655-621",
"deaSchedule": null,
"genericName": "NAPROXEN",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "NAPROXEN",
"strength": "500 mg/1"
}
],
"applicationNumber": "ANDA091416",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20200706",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000000160",
"M0001335",
"N0000175722"
],
"unii": [
"57Y76R9ATQ"
],
"rxcui": [
"198014"
],
"spl_set_id": [
"f32d755e-4984-ee40-e053-2995a90a4ebe"
],
"pharm_class_cs": [
"Anti-Inflammatory Agents, Non-Steroidal [CS]"
],
"pharm_class_epc": [
"Nonsteroidal Anti-inflammatory Drug [EPC]"
],
"pharm_class_moa": [
"Cyclooxygenase Inhibitors [MoA]"
],
"manufacturer_name": [
"Northwind Health Company, LLC"
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:51655-621_494f2182-140c-e7cc-e063-6394a90a093a"